In Australia, about 43% of people aged between 16 and 85 had experienced a mental disorder at some point as of 2023. Between 2021 and 2022, over 44 million mental health-related meds, largely anti-depressants, were dispensed. While traditional treatments are only about 20 to 30% effective in treating anxiety and depression, recreational cannabis company Melodiol
Read More
After changing its name and identity, cannabis and psychedelics provider Melodiol (ASX: ME1) has decided to sell off two of its most prominent business units, Sierra Sage Herbs and Halucenex Life Sciences to US-based Panacea Life Sciences for $7.56 million in cash and shares. Panacea Life Sciences focuses on the production, research, and distribution of
Read More
According to the Australian Department of Health, half of us will experience some form of mental illness in our lifetime. Treatment is somewhat limited to prescription medications and psychotherapy. However, the current mental health crisis has seen researchers and practitioners alike wondering- is there a better way to approach these frighteningly common conditions? Enter psychedelics,
Read More